BRNS Stock Analysis: Buy, Sell, or Hold?
BRNS - Barinthus Biotherapeutics plc American Depositary Shares
$0.59
-0.01 (-1.48%)
▼
5d:
-1.34%
30d:
-11.79%
90d:
-13.1%
HOLD
MODERATE Confidence
Analysis Updated: Aug 14, 2026 12:00 AM ET
Earnings: Aug 06, 2026
0d
Get Alerted When BRNS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: BRNS shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: BRNS shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: BRNS is currently trading at $0.59, which is considered fair relative to its 30-day fair value range of $0.57 to $0.63.
Technical Outlook: Technically, BRNS is showing sideways momentum. Immediate support is located at $0.55, while resistance sits at $0.63.
Market Sentiment: The stock scores a mixed 46/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $5.00 (+746.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, BRNS is showing sideways momentum. Immediate support is located at $0.55, while resistance sits at $0.63.
Market Sentiment: The stock scores a mixed 46/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $5.00 (+746.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$0.57 -
$0.63
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.7%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (46/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 746.0% below Wall St target ($5.00)
- NEUTRAL: Bottoming setup forming (46/100) — watch for confirmation
Trading Range Analysis
30-Day Trading Range
$0.57 -
$0.63
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$0.55
Resistance Level
$0.63
Current Trend
Sideways
Technical data as of
Aug 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.49
Wall Street Target
$5.00
(+746.0%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: August 15, 2026 12:36 AM ET
Data refreshes hourly during market hours. Next update: 1:36 AM
Data refreshes hourly during market hours. Next update: 1:36 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BRNS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$282 | 66 BUY |
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$88 | 37 SELL |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$34 | 41 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$106 | 50 HOLD |
|
MIRM
Mirum Pharmaceuticals Inc |
STRONG BUY
10 analysts |
$140 | 67 BUY |
